These observations support the notion that soluble aggregates of Aβ and PrP may compete for binding to PrPCin vivo and that the balance between the levels of these aggregates is a critical determinant of whether and what form of neurodegenerative disease will result. Here, PRNP is linked to neurodegenerative disease.